Article Text

Download PDFPDF
CASE REPORT
Takayasu arteritis with multiple coronary involvement and early graft relapse
  1. Leonardo Miranda Macedo1,
  2. Neiberg de Alcantara Lima2,
  3. Ricardo Lessa de Castro Junior2 and
  4. Susan Faragher Bannon2
  1. 1 Internal Medicine, Universidade Federal do Ceara, Fortaleza, CE, Brazil
  2. 2 Internal Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, USA
  1. Correspondence to Dr Neiberg de Alcantara Lima, neiberg.lima{at}med.wmich.edu

Abstract

Coronary artery disease (CAD) due to Takayasu arteritis (TA) is rare. This article reports a case of severe involvement of multiple coronary arteries in a young woman. She was treated with coronary artery bypass grafting and had an early venous graft stenosis despite immunosuppressants. She became asymptomatic one year after a drug-eluting stent placement. This report shows the complexity of the diagnostic and therapeutic approach to TA with complex CAD.

  • ischaemic heart disease
  • vasculitis

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors LMM: conception of the work, data analysis and interpretation, drafting the article, critical revision of the article and final approval of the version to be published. NdAL: conception of the work, data analysis and interpretation, drafting the article, critical revision of the article and final approval of the version to be published. RLdC Jr: data collection, critical revision of the article and final approval of the version to be published. SFB: drafting the article, critical revision of the article and final approval of the version to be published.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.